Amicus Therapeutics Inc (FOLD)
10.40
-0.03
(-0.29%)
USD |
NASDAQ |
May 03, 16:00
10.40
0.00 (0.00%)
After-Hours: 20:00
Amicus Therapeutics Stock Buybacks (Quarterly): -29.83M for Dec. 31, 2023
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -29.83M |
September 30, 2023 | -36.56M |
June 30, 2023 | -24.20M |
March 31, 2023 | -2.354M |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | -199.75M |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | -188.99M |
March 31, 2019 | |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | -294.58M |
December 31, 2017 | -0.001M |
Date | Value |
---|---|
September 30, 2017 | -243.04M |
June 30, 2017 | |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | -39.25M |
June 30, 2016 | -57.82M |
March 31, 2016 | |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.174M |
June 30, 2015 | -243.22M |
March 31, 2015 | |
December 31, 2014 | -97.07M |
September 30, 2014 | -20.39M |
June 30, 2014 | -18.34M |
March 31, 2014 | |
December 31, 2013 | -15.00M |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | -18.14M |
June 30, 2012 | 0.006M |
March 31, 2012 | -62.06M |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-199.75M
Minimum
Sep 2021
--
Maximum
Sep 2019
-32.11M
Average
--
Median
Sep 2019
Stock Buybacks (Quarterly) Benchmarks
TG Therapeutics Inc | 0.001M |
Geron Corp | -141.00M |
Vanda Pharmaceuticals Inc | -- |
Fate Therapeutics Inc | -- |
Editas Medicine Inc | 0.00 |